Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Research

Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease

Authors: Gunadi, Nova Yuli Prasetyo Budi, Alvin Santoso Kalim, Wiwid Santiko, Fuad Dheni Musthofa, Kristy Iskandar, Akhmad Makhmudi

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

MicroRNAs (miRNAs) have been associated with the Hirschsprung disease (HSCR) pathogenesis, however, the findings are still inconclusive. We aimed to investigate the effect of miRNA-206 and its targets, fibronectin 1 (FN1), serum deprivation response (SDPR), and paired box 3 (PAX3) expressions on multifactorial HSCR in Indonesia, a genetically distinct group within Asia.

Methods

We determined the miRNA-206, FN1, SDPR and PAX3 expressions in both the ganglionic and aganglionic colon of HSCR patients and control colon by quantitative real-time polymerase chain reaction (qRT-PCR).

Results

Twenty-one sporadic HSCR patients and thirteen controls were ascertained in this study. The miRNA-206 expression was up-regulated (2-fold) in the ganglionic colon and down-regulated (0.5-fold) in the aganglionic colon compared to the control group (ΔCT 12.4 ± 3.0 vs. 14.1 ± 3.9 vs. 13.1 ± 2.7), but these differences did not reach significant levels (p = 0.48 and p = 0.46, respectively). Interestingly, the FN1 expression was significantly increased in both the ganglionic (38-fold) and aganglionic colon (18-fold) groups compared to the control group ΔCT 5.7 ± 3.0 vs. 6.8 ± 2.3 vs. 11.0 ± 5.0; p = 0.001 and p = 0.038, respectively). Furthermore, the expressions of SDPR were similar in the ganglionic, aganglionic and control colon groups (ΔCT 2.4 ± 0.6 vs. 2.2 ± 0.4 vs. 2.1 ± 0.6; p = 0.16 and p = 0.39, respectively), while no change was observed in the PAX3 expression between the ganglionic, aganglionic, and control colon groups (ΔCT 3.8 ± 0.8 vs. 4.1 ± 0.8 vs. 3.7 ± 1.1; p = 0.83 and p = 0.44, respectively).

Conclusion

Our study is the first report of aberrant FN1 expressions in the colon of patients with HSCR and supplies further insights into the contribution of aberrant FN1 expression in the HSCR pathogenesis.
Literature
1.
go back to reference Alves MM, Sribudiani Y, Brouwer RW, et al. Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model. Dev Biol. 2013;382:320–9.CrossRef Alves MM, Sribudiani Y, Brouwer RW, et al. Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model. Dev Biol. 2013;382:320–9.CrossRef
2.
go back to reference Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1–14.CrossRef Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1–14.CrossRef
3.
go back to reference Emison ES, Garcia-Barcelo M, Grice EA, et al. Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet. 2010;87:60–74.CrossRef Emison ES, Garcia-Barcelo M, Grice EA, et al. Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet. 2010;87:60–74.CrossRef
4.
go back to reference Gunadi, Budi NYP, Sethi R, et al. NRG1 variant effects in patients with Hirschsprung disease. BMC Pediatr. 2018;18:292.CrossRef Gunadi, Budi NYP, Sethi R, et al. NRG1 variant effects in patients with Hirschsprung disease. BMC Pediatr. 2018;18:292.CrossRef
5.
go back to reference Gunadi, Kapoor A, Ling AY, et al. Effects of RET and NRG1 polymorphisms in Indonesian patients with Hirschsprung disease. J Pediatr Surg. 2014;49:1614–8.CrossRef Gunadi, Kapoor A, Ling AY, et al. Effects of RET and NRG1 polymorphisms in Indonesian patients with Hirschsprung disease. J Pediatr Surg. 2014;49:1614–8.CrossRef
6.
go back to reference Sergi CM, Caluseriu O, McColl H, Eisenstat DD. Hirschsprung's disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives. Pediatr Res. 2017;81:177–91.CrossRef Sergi CM, Caluseriu O, McColl H, Eisenstat DD. Hirschsprung's disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives. Pediatr Res. 2017;81:177–91.CrossRef
7.
go back to reference Sharan A, Zhu H, Xie H, Li H, Tang J, Tang W, Zhang H, Xia Y. Down-regulation of miR-206 is associated with Hirschsprung disease and suppresses cell migration and proliferation in cell models. Sci Rep. 2015;5:9302.CrossRef Sharan A, Zhu H, Xie H, Li H, Tang J, Tang W, Zhang H, Xia Y. Down-regulation of miR-206 is associated with Hirschsprung disease and suppresses cell migration and proliferation in cell models. Sci Rep. 2015;5:9302.CrossRef
8.
go back to reference Tang W, Li H, Tang J, Wu W, Qin J, Lei H, et al. Specific serum microRNA profile in the molecular diagnosis of Hirschsprung's disease. J Cell Mol Med. 2014;18:1580–7.CrossRef Tang W, Li H, Tang J, Wu W, Qin J, Lei H, et al. Specific serum microRNA profile in the molecular diagnosis of Hirschsprung's disease. J Cell Mol Med. 2014;18:1580–7.CrossRef
9.
go back to reference Tajima A, Pan IH, Fucharoen G, et al. Three major lineages of Asian Y chromosomes: implications for the peopling of east and Southeast Asia. Hum Genet. 2002;110:80–8.CrossRef Tajima A, Pan IH, Fucharoen G, et al. Three major lineages of Asian Y chromosomes: implications for the peopling of east and Southeast Asia. Hum Genet. 2002;110:80–8.CrossRef
10.
go back to reference Gunadi, Makhmudi A, Agustriani N, Rochadi. Effects of SEMA3 polymorphisms in Hirschsprung disease patients. Pediatr Surg Int 2016;32:1025–1028. Gunadi, Makhmudi A, Agustriani N, Rochadi. Effects of SEMA3 polymorphisms in Hirschsprung disease patients. Pediatr Surg Int 2016;32:1025–1028.
11.
go back to reference Setiadi JA, Dwihantoro A, Iskandar K, Heriyanto DS. Gunadi. The utility of the hematoxylin and eosin staining in patients with suspected Hirschsprung disease. BMC Surg. 2017;17:71.CrossRef Setiadi JA, Dwihantoro A, Iskandar K, Heriyanto DS. Gunadi. The utility of the hematoxylin and eosin staining in patients with suspected Hirschsprung disease. BMC Surg. 2017;17:71.CrossRef
12.
go back to reference Gunadi, Sunardi M, Budi NYP, Kalim AS, Iskandar K, Dwihantoro A. The impact of down-regulated SK3 expressions on Hirschsprung disease. BMC Med Genet. 2018;19:24.CrossRef Gunadi, Sunardi M, Budi NYP, Kalim AS, Iskandar K, Dwihantoro A. The impact of down-regulated SK3 expressions on Hirschsprung disease. BMC Med Genet. 2018;19:24.CrossRef
13.
go back to reference Yu ZB, Han SP, Bai YF, Zhu C, Pan Y, Guo XR. microRNA expression profiling in fetal single ventricle malformation identified by deep sequencing. Int J Mol Med. 2012;29:53–60.CrossRef Yu ZB, Han SP, Bai YF, Zhu C, Pan Y, Guo XR. microRNA expression profiling in fetal single ventricle malformation identified by deep sequencing. Int J Mol Med. 2012;29:53–60.CrossRef
14.
go back to reference Bluyssen HA, Lolkema MP, van Beest M, et al. Fibronectin is a hypoxia-independent target of the tumor suppressor VHL. FEBS Lett. 2004;556:137–42.CrossRef Bluyssen HA, Lolkema MP, van Beest M, et al. Fibronectin is a hypoxia-independent target of the tumor suppressor VHL. FEBS Lett. 2004;556:137–42.CrossRef
15.
go back to reference Ozturk S, Papageorgis P, Wong CK, et al. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proc Natl Acad Sci U S A. 2016;113:638–43.CrossRef Ozturk S, Papageorgis P, Wong CK, et al. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proc Natl Acad Sci U S A. 2016;113:638–43.CrossRef
16.
go back to reference Shen W, Chen G, Dong R, Zhao R, Zheng S. MicroRNA-21/PTEN/Akt axis in the fibrogenesis of biliary atresia. J Pediatr Surg. 2014;49:1738–41.CrossRef Shen W, Chen G, Dong R, Zhao R, Zheng S. MicroRNA-21/PTEN/Akt axis in the fibrogenesis of biliary atresia. J Pediatr Surg. 2014;49:1738–41.CrossRef
17.
go back to reference Bajpai VK, Kerosuo L, Tseropoulos G, et al. Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates. Stem Cells. 2017;35:1402–15.CrossRef Bajpai VK, Kerosuo L, Tseropoulos G, et al. Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates. Stem Cells. 2017;35:1402–15.CrossRef
18.
go back to reference Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–8.CrossRef Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–8.CrossRef
19.
go back to reference Huang RS, Gamazon ER, Ziliak D, et al. Population differences in microRNA expression and biological implications. RNA Biol. 2011;8:692–701.CrossRef Huang RS, Gamazon ER, Ziliak D, et al. Population differences in microRNA expression and biological implications. RNA Biol. 2011;8:692–701.CrossRef
20.
go back to reference Theodore S, Rhim J, Turner T, Yates C. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis. 2010;20:96–100. Theodore S, Rhim J, Turner T, Yates C. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis. 2010;20:96–100.
21.
go back to reference Pingault V, Ente D, Dastot-Le Moal F, et al. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010;31:391–406.CrossRef Pingault V, Ente D, Dastot-Le Moal F, et al. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010;31:391–406.CrossRef
22.
go back to reference Van Landeghem L, Mahé MM, Teusan R, et al. Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics. 2009;10:507.CrossRef Van Landeghem L, Mahé MM, Teusan R, et al. Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics. 2009;10:507.CrossRef
23.
go back to reference Gunadi, Iskandar K, Makhmudi A, Kapoor A. Combined genetic effects of RET and NRG1 susceptibility variants on multifactorial Hirschsprung disease in Indonesia. J Surg Res. 2019;233:96–9.CrossRef Gunadi, Iskandar K, Makhmudi A, Kapoor A. Combined genetic effects of RET and NRG1 susceptibility variants on multifactorial Hirschsprung disease in Indonesia. J Surg Res. 2019;233:96–9.CrossRef
24.
go back to reference Gui H, Tang WK, So MT, et al. RET and NRG1 interplay in Hirschsprung disease. Hum Genet. 2013;132:591–600.CrossRef Gui H, Tang WK, So MT, et al. RET and NRG1 interplay in Hirschsprung disease. Hum Genet. 2013;132:591–600.CrossRef
25.
go back to reference Ngan ES, Garcia-Barceló MM, Yip BH, et al. Hedgehog/notch-induced premature gliogenesis represents a new disease mechanism for Hirschsprung disease in mice and humans. J Clin Invest. 2011;121:3467–78.CrossRef Ngan ES, Garcia-Barceló MM, Yip BH, et al. Hedgehog/notch-induced premature gliogenesis represents a new disease mechanism for Hirschsprung disease in mice and humans. J Clin Invest. 2011;121:3467–78.CrossRef
Metadata
Title
Aberrant expressions of miRNA-206 target, FN1, in multifactorial Hirschsprung disease
Authors
Gunadi
Nova Yuli Prasetyo Budi
Alvin Santoso Kalim
Wiwid Santiko
Fuad Dheni Musthofa
Kristy Iskandar
Akhmad Makhmudi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-018-0973-5

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue